Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Oceania Healthcare Limited (OCA.NZ)
NZD0.75
+0.00 (+0.00%)
NZ NZE Healthcare Medical - Care Facilities
Address
80 Queen Street 1010
Auckland, NZ
Auckland, NZ
CEO
Suzanne Dvorak
Website
oceaniahealthcare.co.nz
IPO
2017-05-04
ISIN NZOCAE0002S0
Also trades on
Australian Securities Exchange · OCA.AX (AUD)
New Zealand Exchange · OCA.NZ (NZD)
Description
Oceania Healthcare Limited, headquartered in Auckland, New Zealand, owns and operates a network of retirement villages and aged care facilities across the country. The company's business activities are categorized into three primary segments: Care Operations, Village Operations, and an 'Other' category. It delivers a comprehensive array of services, encompassing residential care for individuals requiring rest home, hospital, or dementia support, alongside independent living units and rental accommodations within its retirement communities. Furthermore, Oceania Healthcare provides essential corporate support services, including administrative functions, marketing efforts, and operational oversight. Founded in 2005, the organization was originally named Retirement Care (NZ) Limited, before rebranding to Oceania Healthcare Limited in September 2014.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
NZD0.75
+0.00 (+0.00%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
595.1K
Beta
0.60
Float Shares
658.56M
Free Float %
90.9%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.67% | +10.29% | +2.74% | -9.64% | -10.18% | -18.48% | +17.19% | -3.85% | -45.65% | -5.06% | -5.06% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
0.75
DCF (Levered)
0.73
-2.2%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
75% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 3 | 0 |
| Hold | 1 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
-0.17
Distress
Piotroski F-Score
7 / 9
Strong
MOAT Score
1 / 10
No MOAT
Composite Rating
A
Overall Score
4 / 5
High
DCF Score
5 / 5
High
ROE Score
3 / 5
Medium
ROA Score
4 / 5
High
D/E Score
2 / 5
Medium
P/E Score
3 / 5
Medium
P/Book Score
5 / 5
High
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Care Facilities: +10.2%+2.5% Q1'26: +99.0% (vs Q3'24)
-
EPS growth Medical - Care Facilities: +19.2%-99.5% Q1'26: +44.2% (vs Q3'24)
-
FCF margin FCF growth · Medical - Care Facilities: +32.0%-3.7% Q1'26: +56.4% (vs Q3'24)
-
EBIT margin Medical - Care Facilities: +11.3%-7.4% Q1'26: -11.6% (vs Q3'24)
-
ROIC Medical - Care Facilities: +6.8%-1.2% Q1'26: -2.2% (vs Q3'24)
-
Share dilution Medical - Care Facilities: +0.0%+0.0% Q1'26: +0.0% (vs Q3'24)
-
Debt / EBITDA Net debt/EBITDA · Medical - Care Facilities: 0.99×131.83× Q1'26: -34.46× (vs Q3'24)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Mar 2017 actual |
Mar 2018 actual |
Mar 2019 actual |
Mar 2020 actual |
Mar 2021 actual |
Mar 2022 actual |
Mar 2023 actual |
Mar 2024 actual |
Mar 2025 actual |
Mar 2026 3 Rev. Ana. 2 EPS Ana. |
Mar 2027 2 Rev. Ana. 2 EPS Ana. |
Mar 2028 3 Rev. Ana. 2 EPS Ana. |
Mar 2029 1 Rev. Ana. 1 EPS Ana. |
Mar 2030 1 Rev. Ana. |
Mar 2031 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
203.50M
est.
|
180.05M
est: 210.73M (-14.6%)
|
186.98M
est: 211.71M (-11.7%)
|
193.65M
est: 205.03M (-5.6%)
|
210.50M
est: 258.94M (-18.7%)
|
231.14M
est: 325.26M (-28.9%)
|
247.18M
est: 328.59M (-24.8%)
|
265.46M
est: 382.39M (-30.6%)
|
260.57M
est: 365.86M (-28.8%)
|
407.04M
363.27M – 485.82M
+11.3% YoY
|
355.20M
343.46M – 366.94M
-12.7% YoY
|
359.28M
321.02M – 405.08M
+1.2% YoY
|
371.16M
344.38M – 402.09M
+3.3% YoY
|
281.30M
261.00M – 304.74M
-24.2% YoY
|
295.65M
274.32M – 320.28M
+5.1% YoY
|
| EBITDA |
47.04M
est.
|
86.42M
est: 48.71M (+77.4%)
|
59.52M
est: 48.94M (+21.6%)
|
-7.01M
est: 47.40M (-114.8%)
|
12.21M
est: 59.86M (-79.6%)
|
88.32M
est: 75.19M (+17.5%)
|
53.36M
est: 75.96M (-29.7%)
|
63.35M
est: 88.39M (-28.3%)
|
68.05M
est: 81.42M (-16.4%)
|
90.59M
80.85M – 108.12M
+11.3% YoY
|
79.05M
76.44M – 81.66M
-12.7% YoY
|
79.96M
71.44M – 90.15M
+1.2% YoY
|
82.60M
76.64M – 89.49M
+3.3% YoY
|
62.60M
58.09M – 67.82M
-24.2% YoY
|
65.80M
61.05M – 71.28M
+5.1% YoY
|
| EBIT |
30.96M
est.
|
77.58M
est: 32.06M (+142.0%)
|
—
est: 32.21M (-100.0%)
|
-21.50M
est: 31.20M (-168.9%)
|
—
est: 39.40M (-100.0%)
|
70.39M
est: 49.49M (+42.2%)
|
35.44M
est: 50.00M (-29.1%)
|
44.37M
est: 58.18M (-23.7%)
|
45.91M
est: 52.49M (-12.5%)
|
58.39M
52.11M – 69.69M
+11.3% YoY
|
50.96M
49.27M – 52.64M
-12.7% YoY
|
51.54M
46.05M – 58.11M
+1.2% YoY
|
53.25M
49.40M – 57.68M
+3.3% YoY
|
40.35M
37.44M – 43.72M
-24.2% YoY
|
42.41M
39.35M – 45.95M
+5.1% YoY
|
| Net Income |
24.26M
est.
|
76.97M
est: 62.18M (+23.8%)
|
45.37M
est: 60.05M (-24.4%)
|
-13.64M
est: 50.71M (-126.9%)
|
102.82M
est: 48.14M (+113.6%)
|
61.13M
est: 54.77M (+11.6%)
|
15.45M
est: 59.90M (-74.2%)
|
31.47M
est: 56.18M (-44.0%)
|
30.42M
est: 51.46M (-40.9%)
|
56.75M
55.53M – 57.97M
+10.3% YoY
|
71.66M
68.23M – 75.10M
+26.3% YoY
|
59.94M
50.45M – 60.52M
-16.4% YoY
|
61.50M
50.30M – 61.52M
+2.6% YoY
|
—
— – —
-100.0% YoY
|
—
— – —
|
| SGA |
118.53M
est.
|
122.36M
est: 122.74M (-0.3%)
|
127.33M
est: 123.31M (+3.3%)
|
147.34M
est: 119.42M (+23.4%)
|
42.21M
est: 150.82M (-72.0%)
|
158.94M
est: 189.45M (-16.1%)
|
164.64M
est: 191.39M (-14.0%)
|
178.79M
est: 222.73M (-19.7%)
|
178.37M
est: 214.90M (-17.0%)
|
239.08M
213.38M – 285.36M
+11.3% YoY
|
208.63M
201.74M – 215.53M
-12.7% YoY
|
211.04M
188.56M – 237.94M
+1.2% YoY
|
218.01M
202.28M – 236.18M
+3.3% YoY
|
165.23M
153.31M – 179.00M
-24.2% YoY
|
173.66M
161.13M – 188.13M
+5.1% YoY
|
| EPS |
0.03
est.
|
0.13
est: 0.09 (+51.4%)
|
0.08
est: 0.08 (-9.6%)
|
-0.02
est: 0.07 (-131.8%)
|
0.17
est: 0.07 (+155.7%)
|
0.09
est: 0.08 (+15.0%)
|
0.02
est: 0.08 (-72.1%)
|
0.04
est: 0.07 (-39.9%)
|
0.04
est: 0.07 (-40.3%)
|
0.08
0.08 – 0.08
+11.7% YoY
|
0.10
0.09 – 0.10
+25.9% YoY
|
0.08
0.07 – 0.08
-22.4% YoY
|
0.08
0.07 – 0.08
-0.2% YoY
|
—
— – —
-100.0% YoY
|
—
— – —
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-27 | A | 4/5 | 5/5 | 3/5 | 4/5 | 2/5 | 3/5 | 5/5 |
| 2026-05-26 | A | 4/5 | 5/5 | 3/5 | 4/5 | 2/5 | 3/5 | 5/5 |
| 2026-05-25 | A | 4/5 | 5/5 | 3/5 | 4/5 | 2/5 | 3/5 | 5/5 |
| 2026-05-22 | A- | 4/5 | 4/5 | 3/5 | 4/5 | 2/5 | 3/5 | 5/5 |
| 2026-05-21 | A- | 4/5 | 4/5 | 3/5 | 4/5 | 2/5 | 3/5 | 5/5 |
| 2026-05-20 | A- | 4/5 | 4/5 | 3/5 | 4/5 | 2/5 | 3/5 | 5/5 |
| 2026-05-19 | A- | 4/5 | 4/5 | 3/5 | 4/5 | 2/5 | 3/5 | 5/5 |
| 2026-05-18 | A- | 4/5 | 4/5 | 3/5 | 4/5 | 2/5 | 3/5 | 5/5 |
| 2026-05-15 | A- | 4/5 | 4/5 | 3/5 | 4/5 | 2/5 | 3/5 | 5/5 |
| 2026-05-14 | A- | 4/5 | 4/5 | 3/5 | 4/5 | 2/5 | 3/5 | 5/5 |
| 2026-05-13 | A- | 4/5 | 4/5 | 3/5 | 4/5 | 2/5 | 3/5 | 5/5 |
| 2026-05-12 | A- | 4/5 | 4/5 | 3/5 | 4/5 | 2/5 | 3/5 | 5/5 |
| 2026-05-11 | A- | 4/5 | 4/5 | 3/5 | 4/5 | 2/5 | 3/5 | 5/5 |
| 2026-05-08 | B+ | 3/5 | 4/5 | 3/5 | 3/5 | 1/5 | 3/5 | 5/5 |
| 2026-05-07 | B+ | 3/5 | 4/5 | 3/5 | 3/5 | 1/5 | 3/5 | 5/5 |
| 2026-05-06 | B+ | 3/5 | 4/5 | 3/5 | 3/5 | 1/5 | 3/5 | 5/5 |
| 2026-05-05 | B+ | 3/5 | 4/5 | 2/5 | 3/5 | 1/5 | 3/5 | 5/5 |
| 2026-05-04 | B+ | 3/5 | 4/5 | 2/5 | 3/5 | 1/5 | 3/5 | 5/5 |
| 2026-05-01 | B+ | 3/5 | 4/5 | 2/5 | 4/5 | 1/5 | 3/5 | 5/5 |
| 2026-04-30 | B+ | 3/5 | 4/5 | 2/5 | 4/5 | 1/5 | 3/5 | 5/5 |
| 2026-04-29 | B+ | 3/5 | 4/5 | 2/5 | 4/5 | 1/5 | 3/5 | 5/5 |
| 2026-04-28 | B+ | 3/5 | 4/5 | 2/5 | 4/5 | 1/5 | 3/5 | 5/5 |
| 2026-04-24 | B+ | 3/5 | 4/5 | 2/5 | 4/5 | 1/5 | 3/5 | 5/5 |
| 2026-04-23 | B+ | 3/5 | 4/5 | 2/5 | 4/5 | 1/5 | 3/5 | 5/5 |
| 2026-04-22 | B+ | 3/5 | 4/5 | 2/5 | 4/5 | 1/5 | 3/5 | 5/5 |
| 2026-04-21 | B+ | 3/5 | 4/5 | 2/5 | 4/5 | 1/5 | 3/5 | 5/5 |
| 2026-04-20 | B+ | 3/5 | 4/5 | 2/5 | 4/5 | 1/5 | 3/5 | 5/5 |
| 2026-04-17 | B+ | 3/5 | 4/5 | 2/5 | 4/5 | 1/5 | 3/5 | 5/5 |
| 2026-04-16 | B+ | 3/5 | 4/5 | 2/5 | 4/5 | 1/5 | 3/5 | 5/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
552.04M
OE per share TTM
0.76
Owner's Yield
102.31%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
306.0%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
Held by 29 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Dimensional - International Small Cap ETF DFIS | 0.01% | 452.2K | 0.39% |
| 2 | Vanguard FTSE All-World ex-US Small-Cap ETF VSS | 0.01% | 1.09M | 0.06% |
| 3 | Avantis International Small Cap Value ETF AVDV | 0.01% | 1.43M | 0.36% |
| 4 | Vanguard FTSE Pacific ETF VPL | 0.00% | 389.0K | 0.07% |
| 5 | Dimensional - International Vector Equity ETF DXIV | 0.00% | 4.8K | 0.53% |
| 6 | Dimensional - International Core Equity 2 ETF DFIC | 0.00% | 352.8K | 0.22% |
| 7 | Vanguard FTSE Developed Asia Pacific All Cap Index ETF VA.TO | 0.00% | 5.7K | 0.22% |
| 8 | Dimensional World ex U.S. Core Equity 2 ETF DFAX | 0.00% | 198.2K | 0.28% |
| 9 | Vanguard FTSE Developed All Cap ex North America Index ETF (CAD-hedged) VI.TO | 0.00% | 6.7K | 0.22% |
| 10 | Vanguard FTSE Developed All Cap ex North America Index ETF VIU.TO | 0.00% | 78.0K | 0.23% |
Insider Activity
Insider Activity — Latest Quarter
No insider activity available.
Insider buys vs sells (history)
Insider history not available.
Recent insider transactions
No recent insider transactions.
Executive team
Top executives
EBIT / Employee
-7.3K
Shares Outstanding
724.23M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Suzanne Dvorak | Chief Executive Officer | 2M | female |
| Fiona Cameron | Chief Sales & Marketing Officer | — | female |
| Kathryn Waugh | Chief Financial Officer | — | female |
| Sarah Miller | Chief Legal & Corporate Services Officer | — | female |
ESG Score History
No data available for this company.
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for OCA.NZ
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
